Bank Of America Corp Theratechnologies Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.01 $348 - $451	-447 Reduced 8.77%	4,650 $3,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.12 $537 - $836	747 Added 17.17%	5,097 $4,000
Q4 2022 Feb 10, 2023	SELL	$0.83 - $8.04 $614 - $5,949	-740 Reduced 14.54%	4,350 $3,000
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $1,007 - $1,231	509 Added 11.11%	5,090 $11,000
Q2 2022 Aug 12, 2022	BUY	$2.21 - $2.7 $510 - $623	231 Added 5.31%	4,581 $10,000
Q1 2022 May 16, 2022	SELL	$2.37 - $3.24 $4,680 - $6,399	-1,975 Reduced 31.23%	4,350 $11,000
Q4 2021 Feb 08, 2022	BUY	$2.92 - $3.76 $5,767 - $7,426	1,975 Added 45.4%	6,325 $19,000
Q2 2021 Sep 13, 2021	BUY	$3.43 - $3.96 $14,920 - $17,226	4,350 New	4,350 $17,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $115M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.